Cite
MLA Citation
K. Suleman et al.. “Retrospective review of Her2 positive metastatic breast cancer patients who received Pertuzumab and Herceptin as a first line therapy at KFSH&RC (single institute experience) from 2013 to 2016.” Breast, vol. 44, n.d., pp. S64–. http://access.bl.uk/ark:/81055/vdc_100080179681.0x00001e